Abstract:Disease modelling is vital for improving knowledge of disease mechanisms and for development of new therapeutic molecules and strategies. Modelling the intact living tumour microenvironment (TME) is increasingly considered to be vital not only for gaining a better understanding of the biology of cancer but for examining the efficacy of novel oncology drugs. To date, pre-clinical mouse models of cancer have represented the mainstay methodology for studying the evolving TME and for determining the effects of potential therapeutic molecules on tumour evolution and growth. Regarding drug screening, mouse models are expensive, require the use of large cohorts of mice and involve the administration of drugs with unknown toxicities to animals which often result in adverse effects that can cause animal suffering and the discontinuation of drug investigations. Hepatocellular carcinoma (HCC) is a primary cancer of the liver for which there is an urgent need for improved systemic treatments due to the disease usually being diagnosed at an advanced stage and current treatments having limited efficacy. To provide a practical solution to the screening of drugs for their likely efficacy in HCC we have developed an model in which orthotopic tumours are excised from the liver and subsequently processed to generate precision-cut tumour slices (PCTS) which provide an intact culture model of the HCC-TME. We describe simplified culture conditions that maintain the viability and metabolic activity of live PCTS which maintain the architecture, cellular complexity, drug sensitivity and responsiveness to immunotherapy of the original tumour. Importantly, we show that HCC derived PCTS can be miniaturised to 96-well scale and modified to express soluble luciferase, which in combination enabled non-destructive screening of a library of 26 drugs at two doses using just 5 tumours as the source for PCTS. This screen identified two small molecules, salinomycin and rottlerin, that have potent anti-tumour activities in HCC-PCTS and subsequently validated salinomycin as effective . In summary, we report a 3Rs (reduction, refinement and replacement) solution for study of HCC biology and for 96-well-scale screening of potential therapeutic agents in the context of an intact, metabolically active TME.

Optimizing in-vivo phage display combined with laser capture microdissection and real-time PCR to the study of vascular heterogeneity in hepatocellular carcinoma

Application and optimization of in vivo phage display in study of vascular heterogeneity in hepatocellular carcinoma

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Microvessels in hepatocellular carcinoma and focal nodular hyperplasia:a comparison by immunohistochemical staining

In vitro vascularized liver tumor model based on a microfluidic inverse opal scaffold for immune cell recruitment investigation

Studying tumor metastasis by in vivo imaging and flow cytometer

Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes

Mesoscale visualization of three-dimensional microvascular architecture and immunocyte distribution in intact mouse liver lobes

Liver cancer patient source heterotransplantation tumour mouse model and construction method thereof

In-line X-ray phase-contrast imaging of murine liver microvasculature ex vivo

Optimization of human hepatocellular cell clones with high lymphatic metastasis potential and the establishment of nude mouse model

Non-invasive visualization of tumors in the mouse liver using a novel nanoparticle contrast enhanced micro-CT imaging procedure

Use of Multiphoton Microscopy to Diagnose Liver Cancer and Lung Metastasis in an Orthotopic Rat Model

The Establishment of Metastatic Human Hepatocellular Carcinoma Orthotopic Transplantation Model in Combination with Hepatic Artery Ligation in Nude Mice

A Preliminary Study of Phase Contrast X-ray Imaging with Synchrotron Radiation

mouse precision cut tumour slices for modelling hepatocellular carcinoma; A 3Rs solution for at-scale drug screening

Preclinical study of using multiphoton microscopy to diagnose liver cancer and differentiate benign and malignant liver lesions.

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging

Comprehensive Comparison Of Patient-Derived Xenograft Models In Hepatocellular Carcinoma And Metastatic Liver Cancer

Quantitative assessment of hepatic steatosis using label-free multiphoton imaging and customized image processing program